en
de
Contact
COMPANY
PORTFOLIO
INVESTORS
Search
Sitemap
COMPANY
Profile
Organisation
Board of Directors
Management
Cayman Subsidiary
Investment Manager
Investment Advisor Europe
Investment Advisor USA
Corporate Governance
Articles of Association
PORTFOLIO
Overview
Largest Investments
Portfolio News
INVESTORS
Share Price
Net Asset Value (NAV)
Financial Reports
Financial year 2011/2012
Financial year 2010/2011
Archive
Financial year 2009/2010
Financial year 2008/2009
Financial year 2007/2008
Financial year 2006/2007
Financial year 2005/2006
Financial year 2004/2005
Financial year 2003/2004
Financial year 2002/2003
Financial year 2001/2002
Press Releases
Archive
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
Presentations
Investment Guidelines
Significant Shareholders
Management Transactions
Calendar
FAQ
News Service
News
HBM BioVentures publishes annual results for 2011/12
Enanta signs significant collaboration agreement with Novartis for Hepatitis C programme
more
Financial Reports
Quarterly Report December 2011
more
Company Presentation
more
Share Price
SIX Swiss Exchange Ticker
HBMN
Key Figures
as at 15 May 2012
CHF
NAV per share
58.98
Net assets
533 Mio.
© HBM BioVentures Ltd
Credits
Important legal information